We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$53.2M
AUM Growth
-$21.3M
Cap. Flow
-$17.4M
Cap. Flow %
-32.71%
Top 10 Hldgs %
96.55%
Holding
18
New
2
Increased
1
Reduced
3
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 61.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USO icon
1
CALL
United States Oil Fund
USO
$2.54B
$11.3M 21.3%
173,500
-180,000
-51% -$13.2M
SVRA icon
2
Savara
SVRA
$1.13B
$10.7M 20.1%
6,896,551
XERS icon
3
Xeris Biopharma Holdings
XERS
$1.5B
$9.42M 17.72%
6,039,028
SPY icon
4
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$5.7M 10.71%
15,947
SCYX icon
5
SCYNEXIS
SCYX
$44.5M
$4.14M 7.78%
215,493
RZLT icon
6
Rezolute
RZLT
$421M
$3.85M 7.23%
1,403,157
XOP icon
7
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.48B
$2.18M 4.1%
+17,500
New +$2.31M
MTEM
8
DELISTED
Molecular Templates, Inc.
MTEM
$1.54M 2.89%
136,866
ACLX
9
DELISTED
Arcellx
ACLX
$1.43M 2.69%
76,186
-25,533
-25% -$489K
AMLP icon
10
Alerian MLP ETF
AMLP
$12.7B
$1.08M 2.03%
+29,500
New +$1.12M
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$880K 1.65%
3,896
VECT
12
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$845K 1.59%
140,863
-53,714
-28% -$292K
ELEV
13
DELISTED
Elevation Oncology
ELEV
$77K 0.14%
68,297
+4
+0% +$5
FLACW
14
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$17K 0.03%
21,333
LUXAW
15
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$9K 0.02%
66,666
BTWNW
16
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$5K 0.01%
39,773
PV.WS
17
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$2K ﹤0.01%
12,000
GLD icon
18
SPDR Gold Trust
GLD
$130B
-40,820
Closed -$6.88M

Similar funds

Caxton Corporation's Q3 2022 Portfolio in Review

As of Q3 2022, Caxton Corporation held 18 positions worth $53.2M, down 29% from $74.4M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Caxton Corporation withdrew a net $17.4M in Q3 2022, closing 1 position and reducing 3 holdings. Its most notable exit was SPDR Gold Trust, an estimated $6.88M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 44% a quarter earlier.

Against the trend, Caxton Corporation opened a new position in State Street SPDR S&P Oil & Gas Exploration & Production ETF worth $2.18M.

  • Caxton Corporation's largest Q3 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 17,500 shares worth $2.18M.
  • Caxton Corporation added most to Elevation Oncology in Q3 2022, an estimated $5 increase.
  • Caxton Corporation's biggest Q3 2022 reduction was Arcellx, cutting an estimated $489K.
  • Caxton Corporation fully exited SPDR Gold Trust in Q3 2022, selling an estimated $6.88M.
  • Caxton Corporation's ten largest holdings make up 97% of its $53.2M portfolio in Q3 2022.
  • Caxton Corporation opened 2 new positions and closed 1 in Q3 2022.
  • Caxton Corporation's portfolio value fell 29% quarter-over-quarter to $53.2M.

Based on Caxton Corporation's 13F filing for Q3 2022, filed 14 Nov 2022.